A Phase 2, randomized, double-blind, placebo-controlled multi-center trial sub-study for the clinical effects of paridiprubart treatment in hospitalized critically ill patients with COVID-19 ARDS

Blair Gordon, Fiona Allum, Michael Brooks, Nishani Rajakulendran, Emmanouil Rampakakis, John Sampalis, EB05 Study Investigators
doi: https://doi.org/10.1101/2023.09.21.23295853

Data Availability

All data produced in the present work are contained in the manuscript.

Back to top
Posted September 27, 2023.
Download PDF
Data/Code
Email
A Phase 2, randomized, double-blind, placebo-controlled multi-center trial sub-study for the clinical effects of paridiprubart treatment in hospitalized critically ill patients with COVID-19 ARDS
Blair Gordon, Fiona Allum, Michael Brooks, Nishani Rajakulendran, Emmanouil Rampakakis, John Sampalis, EB05 Study Investigators
medRxiv 2023.09.21.23295853; doi: https://doi.org/10.1101/2023.09.21.23295853
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area